3D Tissue Models
5th Annual Symposium on PET/CT and Molecular Imaging
Wynn Las Vegas
3131 Las Vegas Boulevard South
Las Vegas, Nevada
5th Annual Symposium on PET/CT and Molecular Imaging

Schedule of Presentations:

Thursday, February 11, 2010
07:30:00 Registration & Check-in, Continental Breakfast
08:00:00 PET/CT: The Field Continues to Expand Andrew Quon
08:00:00 Welcome and Announcements Andrew Quon
08:10:00 PET/CT State-of-the-Union: The Success of the Past 8 Years and a Look to the Future George Segall
09:00:00 30Reviewing the Changes in PET/CT Reimbursement (Thank you, NOPR trial) Johannes Czernin
09:30:00 The Increasing Use of PET/CT by Radiation Oncologists Rathan Subramaniam
10:00:00 Coffee Break
10:30:00 Utility of FDG PET in Sarcoma Johannes Czernin
10:30:00 Oncology In-Depth Johannes Czernin
11:00:00 Use of PET/CT in Judging Response to Therapy David K. Shelton
11:30:00 Updates on PET/CT and Thyroid Cancer Andrei Iagaru
12:00:00 Recess for Lunch
13:30:00 PET in Pediatric Oncology Andrew Quon
14:00:00 Wait, Wait... Don't Tell Me! What Do You Believe in PET/CT? Andrew Quon
14:20:00 What is the SUV Cut-Off for Lung Cancer? Johannes Czernin, David K. Shelton
14:30:00 Dual Timepoint PET: Yes or No? George Segall
14:45:00 Pick Your Poison with Bone Metastases: MDP or FDG? Homer A. Macapinlac, Marc Seltzer
15:00:00 Coffee Break
15:15:00 PET/CT Interpretation George Segall
15:20:00 PET/CT Slice-by-Slice: Neck and Chest Rathan Subramaniam
16:15:00 Tips on Differentiating the 3 "R's" in Post-Tx PET/CT: Residual vs. Recurrence vs. Resolution (vs. Inflammation) George Segall
16:45:00 Interpreting the Lungs and Mediastinum Post-XRT: Pearls and Pitfalls Marc A. Seltzer
Friday, February 12, 2010
07:30:00 Continental Breakfast
08:00:00 PET/CT Advanced Users Andrew Quon
08:00:00 Utility of PET and MRI Software Fusion for Brain Tumor Evaluation Michael L. Goris
08:30:00 PET/CT for Infection: Blessing or a Curse Homer A. Macapinlac
09:00:00 Clinical Scenarios Where PET is Helpful in Small Cell Lung, Prostate, and Myeloma Rathan Subramaniam
09:30:00 Imaging "The Prodigal Tumors": PET and Pancreatic, Hepatic, Small Bowel, Renal, Adrenal, and Metastastic Cancers Homer A. Macapinlac
10:00:00 Coffee Break
10:20:00 PET/CT Clinical Update Michael L. Goris
10:20:00 Radiolabeled Microsphere Treatment and Monitoring with PET: My Experience with Our First 100 Patients Michael L. Goris
11:00:00 Optimizing Metrics for Interpretation: 3D Volumetric SUV and Total Body Tumor Burden Erik Mittra
11:20:00 Evaluating Pelvic Tumors Homer A. Macapinlac
12:00:00 Integrated MRI/PET Scanners: Technology Update David K. Shelton
12:20:00 Recess for Lunch
13:50:00 PET/CT Interpretation George Segall
13:50:00 PET/CT Slice-by-Slice: Abdomen and Pelvis George Segall
14:35:00 Misadventures of PET/CT Interpretation and Reporting Marc Seltzer
15:20:00 Coffee Break
15:40:00 Mano-a-Mano: The 2nd Annual PET/CT Interpretation Faculty Face-Off Andrew Quon
15:40:00 Unknown cases are presented and interpreted by the Course Faculty with results provided by the Moderator
15:45:00 Round 1: Marc Seltzer, Johannes Czernin
16:00:00 Round 2: Erik Mittra, George Segall
17:00:00 Round 3: Andrei Iagaru, Rathan Subramaniam
Saturday, February 13, 2010
07:30:00 Continental Breakfast
07:40:00 PET/CT Clinic Kent Hutchings
08:00:00 The Fundamental Issues and Challenges of Training PET/CT Technologists Kent Hutchings
08:30:00 Common PET/CT Protocol Issues Erik Mittra
09:00:00 Best Practice Guidelines for PET/CT Technologists Kent Hutchings
09:30:00 Stanford PET/CT Weekly Case Conference: Best Cases from the Past Year Erik Mittra
10:30:00 MRI (Whole Body, DCE, DWI) vs PET: Is PET Still Best for Oncology? Andrei Iagaru
11:00:00 Coffee Break
11:20:00 PET/CT: The Big Picture Andrei Iagaru
11:25:00 An Integrated Approach for the Early Detection of Cancer Andrei Iagaru
13:00:00 Opportunities for Q&A will be provided at the conclusion of each presentation.
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.